The results indicated that high PROS1 expression was related to poor survival in several cancers (LGG, BCLA, STES, STAD, and UVM), and the pan-cancer analysis demonstrated similar results for disease-specific survival, disease-free interval, and progression-free interval (Additional file 1: Figs. S7–S9). This evidence concerns the gene PROS1 and cancer.